Skip to the content Skip to the Navigation
GEXVal
  • HOME
  • Our company
    • CEO message
    • Corporate philosophy
    • Origin of the company name
    • Corporate symbol and color
    • Company profile
    • Team
  • Business Model
  • Pipeline
  • To investors
  • News
    • IR
    • Information
    • R&D
  • Contact
  • Language
    • 日本語
    • English
    • 中文 (簡体字)
    • 中文 (繁体字)
News
  1. Top page
  2. News
  3. Information

Information

Information
Announcement of the 299th Japan Pharmaceutical Licensing Association (JPLA) Regular Meeting
2022/2/24

GEXVal Inc.February 24, 2022 Announcement of the 299th Japan Pharmaceutical Licensing Association (JPLA) Regul […]

Read more
Information
Presentation in New Year’s Social Event of Independence Club
2022/1/12

GEXVal Inc.January 12, 2022 CEO of GEXVal Inc., Dr. Juran Kato, presented at the New Year’s Social Event of th […]

Read more
Information
Lecture by CEO Dr. Kato in “Introduction – Diseases and Drugs” Class in Kyoto Sangyo University
2021/11/30

Read more
Information
Lecture at the 94th Annual Meeting of the Japanese Biochemical Society
2021/10/1

Read more
Information
GEXVal Listed in The Directory of Biotech Startups in Japan 2021-2022 by Nikkei Biotechnology and Business
2021/9/14

Read more

Posts pagination

  • «
  • Page 1
  • …
  • Page 7
  • Page 8
  • Page 9
  • …
  • Page 15
  • »

Category

  • Information
  • IR
  • R&D

Copyright © GEXVal All Rights Reserved.

Powered by WordPress with Lightning Theme & VK All in One Expansion Unit

MENU
  • HOME
  • Our company
    • CEO message
    • Corporate philosophy
    • Origin of the company name
    • Corporate symbol and color
    • Company profile
    • Team
  • Business Model
  • Pipeline
  • To investors
  • News
    • IR
    • Information
    • R&D
  • Contact
  • Language
    • 日本語
    • English
    • 中文 (簡体字)
    • 中文 (繁体字)